Cargando…

Sustained CD19(+)CD27(+) Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

Detalles Bibliográficos
Autores principales:	BOCH, Katharina, LANGAN, Ewan A., SCHMIDT, Enno, ZILLIKENS, Detlef, LUDWIG, Ralf J., BIEBER, Katja, HAMMERS, Christoph M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631286/ https://www.ncbi.nlm.nih.gov/pubmed/35312020 http://dx.doi.org/10.2340/actadv.v102.907

Ejemplares similares

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
por: Boch, Katharina, et al.
Publicado: (2021)

Lichen Planus
por: Boch, Katharina, et al.
Publicado: (2021)

Milestones in Personalized Medicine in Pemphigus and Pemphigoid
por: Bieber, Katja, et al.
Publicado: (2021)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
por: Khil'chenko, Stanislav, et al.
Publicado: (2020)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Evaluation of clinical and laboratory characteristics of patients with cutaneous sarcoidosis: A single-center retrospective cohort study
por: Boch, Katharina, et al.
Publicado: (2022)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
por: BAUM, Sharon, et al.
Publicado: (2020)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Electron microscopy of desmosomal structures in the pemphigus human skin organ culture model
por: Radine, Uta Katharina, et al.
Publicado: (2022)

Current Clinical Trials in Pemphigus and Pemphigoid
por: Izumi, Kentaro, et al.
Publicado: (2019)

Gene Expression Analysis Reveals Novel Shared Gene Signatures and Candidate Molecular Mechanisms between Pemphigus and Systemic Lupus Erythematosus in CD4(+) T Cells
por: Sezin, Tanya, et al.
Publicado: (2018)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
por: Dolenc‐Voljč, Mateja, et al.
Publicado: (2022)

Identification of novel therapeutic targets for blocking acantholysis in pemphigus
por: Burmester, Imke A.K., et al.
Publicado: (2020)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
por: Hofrichter, Maxi, et al.
Publicado: (2018)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Prevalence of pemphigus and pemphigoid autoantibodies in the general population
por: Prüßmann, Wiebke, et al.
Publicado: (2015)

Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients
por: Boch, Katharina, et al.
Publicado: (2022)

Analysis of T cell repertoires of CD45RO CD4 T cells in cohorts of patients with bullous pemphigoid: A pilot study
por: Niebuhr, Markus, et al.
Publicado: (2022)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
por: Agarwal, Ashwin, et al.
Publicado: (2018)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Fortuna, Giulio, et al.
Publicado: (2021)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
por: Tukaj, Stefan, et al.
Publicado: (2022)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
por: Müller, Ralf, et al.
Publicado: (2010)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
por: Corral, Isabela Soubhia, et al.
Publicado: (2013)

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect
por: Chen, D.M., et al.
Publicado: (2019)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

A Possible Role for CD8+ T Lymphocytes in the Cell-Mediated Pathogenesis of Pemphigus Vulgaris
por: Giurdanella, Federica, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r93b0csh8f9eglo6bl5dsr7riu